Technology, Healthcare, Financials Mar 11, 2022 09:19 AM (GMT+8) · EqualOcean
Galaxy Securities believes that with the introduction of the three child policy and other fertility related policies, the increase of infertility rate and the increase of China's per capita disposable income, the penetration rate of assisted reproduction in China is expected to increase in the future. It is suggested to pay attention to Jinxin reproductive, a high-quality private assisted reproductive institution with technical barriers and license barriers, its acquisition progress and the performance elasticity of the gradual recovery of American business. In addition, we can pay attention to Beikang medical, a leading PGT clinical solution provider in China.
Related companies: